Non-enzymatic modification of aminophospholipids by carbonyl-amine reactions

International Journal of Molecular Sciences

Volumn 14, Issue 2, 2013, Pages 3285-3313

  Naudí, Alba ^a   Jové, Mariona ^a   Ayala, Victòria ^a   Cabré, Rosanna ^a   Portero Otín, Manuel ^a   Pamplona, Reinald ^a  

^a UNIVERSITY OF LLEIDA   (Spain)

Author keywords

Advanced glycation endproducts; Advanced lipoxidation endproducts; Age associated diseases; Aging; Carbonyl compounds; Cell membrane; Lipid peroxidation; Maillard reaction products; Oxidative stress; Phosphatidylethanolamine; Phosphatidylserine

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMINOPHOSPHOLIPID; CARBONYL DERIVATIVE; DEOXYADENOSINE; DEOXYGUANOSINE; FREE RADICAL; MEMBRANE PHOSPHOLIPID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLSERINE; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNSATURATED FATTY ACID;

CHEMICAL MODIFICATION; CHEMICAL REACTION; CHEMICAL STRUCTURE; GLYCATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROPHILICITY; HYDROPHOBICITY; LIPID PEROXIDATION; MASS SPECTROMETRY; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN GLYCOSYLATION; REVIEW; THIN LAYER CHROMATOGRAPHY;

EID: 84875108772     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms14023285     Document Type: Review

References (114)

1. Yeagle, P. The Membranes of Cells; Academic Press: San Diego, CA, USA, 1993; pp. 1-349.
2. Vance, D.E.; Vance, J.E. Biochemistry of Lipids, Lipoproteins and Membranes; Elsevier Science BV: Amsterdam, The Netherlands, 1996; pp. 1-553.
3. Vereb, G.; Szollosi, J.; Matko, J.; Nagy, P.; Farkas, T.; Vigh, L.; Matyus, L.; Waldmann, T.A.; Damjanovich, S. Dynamic, yet structured: The cell membrane three decades after the Singer-Nicolson model. Proc. Natl. Acad. Sci. USA 2003, 100, 8053-8058.
4. Ikeda, M.; Kihara, A.; Igarashi, Y. Lipid asymmetry of the eukaryotic plasma membrana: Functions and related enzymes. Biol. Pharm. Bull. 2006, 29, 1542-1546.
5. Lenoir, G; Williamson, P.; Holthuis, J.C.M. On the origin of lipid asymmetry: The flip side of ion transport. Curr. Opin. Chem. Biol. 2007, 11, 654-661.
6. Dowhan, W. Molecular basis for membrane phospholipid diversity: Why are there so many lipids? Ann. Rev. Biochem. 1997, 66, 199-232.
7. Van Meer, G. Cellular lipidomics. EMBO J. 2005, 24, 3159-3165.
8. Portero-Otín, M.; Bellmunt, M.J.; Ruiz, M.C.; Barja, G.; Pamplona, R. Correlation of fatty acid unsaturation of the major liver mitochondrial phospholipid classes in mammals to their maximum life span potential. Lipids 2001, 36, 491-498.
9. Van Meer, G.; Voelker, D.R.; Feigenson, G.W. Membrane lipids: Where they are and how they behave. Nat. Rev. Mol. Cell Biol. 2008, 9, 112-124.
10. Hermansson, M.; Hokynar, K.; Somerharju, P. Mechanisms of glycerophospholipid homeostasis in mammalian cells. Prog. Lipid Res. 2011, 50, 240-257.
11. Schroit, A.J.; Zwaal, R.F.A. Transbilayer movement of phospholipids in red cell and platelet membranes. Biochim. Biophys. Acta 1991, 1071, 313-329.
12. Balasubramanian, K.; Schroit, A.J. Aminophospholipid asymmetry: A matter of lifeand death. Ann. Rev. Physiol. 2003, 65, 701-734.
13. Wallis, J.G.; Watts, J.L.; Browse, J. Polyunsaturated fatty acid synthesis: What will they think of next? Trends Biochem. Sci. 2002, 27, 467-473.
14. Pamplona, R. Membrane phospholipids, lipoxidative damage and molecular integrity: A causal role in aging and longevity. Biochim. Biophys. Acta 2008, 1777, 1249-1262.
15. Hulbert, A.J.; Pamplona, R.; Buffenstein, R.; Buttemer, W.A. Life and death: Metabolic rate, membrane composition, and life span of animals. Physiol. Rev. 2007, 87, 1175-1213.
16. Moller, M.; Botti, H.; Batthyany, C.; Rubbo, H.; Radi, R.; Denicola, A. Direct measurement of nitric oxide and oxygen partitioning into liposomes and low density lipoprotein. J. Biol. Chem. 2005, 280, 8850-8854.
17. Gamliel, A.; Afri, M.; Frimer, A.A. Determining radical penetration of lipid bilayers with new lipophilic spin traps. Free Radical Biol. Med. 2008, 44, 1394-1405.
18. Holman, R.T. Autoxidation of Fats and Related Substances. In Progress in Chemistry of Fats and Other Lipids; Holman, R.T., Lundberg, W.O., Malkin, T., Eds.; Pergamon Press: London, UK, 1954; pp. 51-98.
19. 2-with unsaturated fatty acids. J. Biol. Chem. 1983, 258, 4759-4761.
20. Esterbauer, H.; Schaur, R.J.; Zollner, H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biol. Med. 1991, 11, 81-128.
21. Aldini, G.; Dalle-Donne, I.; Facino, R.M.; Milzani, A.; Carini, M. Intervention strategies to inhibit protein carbonylation by lipoxidation-derived reactive carbonyls. Med. Res. Rev. 2007, 27, 817-868.
22. Thorpe, S.R.; Baynes, J.W. Maillard reaction products in tissue proteins: New products and new perspectives. Amino Acids 2003, 25, 275-281.
23. Pamplona, R. Advanced lipoxidation end-products. Chem.-Biol. Interact. 2011, 192, 14-20.
24. Terman, A.; Brunk, U.T. Lipofuscin. Int. J. Biochem. Cell Biol. 2004, 36, 1400-1404.
25. West, J.D.; Marnett, L.J. Endogenous reactive intermediates as modulators of cell signalling and cell death. Chem. Res. Toxicol. 2006, 19, 173-194.
26. Baynes, J.W.; Monnier, V.M. The Maillard Reaction in Aging, Diabetes and Nutrition; Liss: New York, NY, USA, 1989.
27. Portero-Otin, M.; Pamplona, R. Is Endogenous Oxidative Protein Damage Envolved in the Aging Process? In Protein Oxidation and Disease; Pietzsch, J., Ed.; Research Signpost: Kerala, India, 2006; pp. 91-142.
28. Baynes, J.W. The Role of Oxidation in the Maillard Reaction in vivo. In The Maillard Reaction: Consequences for the Chemical and Life Sciences; Ika, R., Ed.; John Wiley & Sons: Chichester, UK, 1996; pp. 55-72.
29. Corliss, G.A.; Dugan, L.R. Phospholipid oxidation in emulsions. Lipids 1970, 5, 846-853.
30. Popjak, G.; LeBreton, E. Biochemical Problems of Lipids; Interscience Publishers Inc.: New York, NY, USA, 1956; p. 81.
31. Dillard, C.J.; Tappel, A.L. Fluorescent products from reaction of peroxidizing polyunsaturated fatty acids with phosphatidyl ethanolamine and phenylalanine. Lipids 1973, 8, 183-189.
32. Bidlack, W.R.; Tappel, A.L. Fluorescent products of phospholipids during lipid peroxidation. Lipids 1973, 8, 203-207.
33. Shimasaki, H.; Ueta, N.; Mowri, H.-O.; Inoue, K. Formation of age pigment-like fluorescent substances during peroxidation of lipids in model membranes. Biochim. Biophys. Acta 1984, 792, 123-129.
34. Tsuchida, M.; Miura, T.; Aibara, K. Lipofucsin and lipofucsin-like substances. Chem. Phys. Lipids 1987, 44, 297-325.
35. Jain, S.K.; Hochstein, P. Polymerization of membrane components in aging red blood cells. Biochem. Biophys. Res. Commun. 1980, 92, 247-254.
36. Jain, S.K.; Yip, R.; Hoesch, R.M.; Pramanik, A.K.; Dallman, P.R.; Shohet, S.B. Evidence of peroxidative damage to the erythrocyte membrane in iron deficiency. Am. J. Clin. Nutr. 1983, 37, 26-30.
37. Jain, S.K.; Shohet, S.B. A novel phospholipid in irreversibly sickled cells: Evidence for in vivo peroxidative membrane damage in sickle cell disease. Blood 1984, 63, 362-367.
38. Jain, S.K. The accumulation of malonyldialdehyde, a product of fatty acid peroxidation, can disturb aminophospholipid organization in the membrane bilayer of human erythrocytes. J. Biol. Chem. 1984, 259, 3391-3394.
39. Jain, S.K. In vivo externalization of phosphatidylserine and phosphatidylethanolamine in the membrane bilayer and hypercoagulability by the lipid peroxidation of erythrocytes in rats. J. Clin. Invest. 1985, 76, 281-286.
40. Jain, S.K. Evidence for membrane lipid peroxidation during the in vivo aging of human erythrocytes. Biochim. Biophys. Acta 1988, 937, 205-210.
41. Jain, S.K.; McVie, R.; Duett, J.; Herbst, J.J. Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes 1989, 38, 1539-1543.
42. Jain, S.K. Hyperglycemia can cause membrane lipid peroxidation and osmotic fragility in human red blood cells. J. Biol. Chem. 1989, 264, 21340-21345.
43. Bhuyan, K.C.; Master, R.W.; Coles, R.S.; Bhuyan, D.K. Molecular mechanisms of cataractogenesis: IV. Evidence of phospholipid. malondialdehyde adduct in human senile cataract. Mech. Ageing Dev. 1986, 34, 289-296.
44. Bhuyan, D.K.; Master, R.W.; Bhuyan, K.C. Crosslinking of aminophospholipids in cellular membranes of lens by oxidative stress in vitro. Biochim. Biophys. Acta 1996, 1285, 21-28.
45. Esterbauer, H.; Koller, E.; Slee, R.G.; Koster, J.F. Possible involvement of the lipid-peroxidation product 4-hydroxynonenal in the formation of fluorescent chromolipids. Biochem. J. 1986, 239, 405-409.
46. Guichardant, M.; Taibi-Tronche, P.; Fay, L.B.; Lagarde, M. Covalent modifications of aminophospholipids by 4-hydroxynonenal. Free Radic. Biol. Med. 1998, 25, 1049-1056.
47. Dillard, C.J.; Tappel, A.L. Fluorescent products of lipid peroxidation of mitochondria and microsomes. Lipids 1971, 6, 715-721.
48. Koster, J.F.; Slee, R.G. Lipid peroxidation of rat liver microsomes. Biochim. Biophys. Acta 1980, 620, 489-499.
49. Kikugawa, K.; Ido, Y. Studies on peroxidized lipids. V. Formation and characterization of 1,4-dihydropyridine-3,5-dicarbaldehydes as model of fluorescent components in lipofuscin. Lipids 1984, 19, 600-608.
50. Hadley, M.; Draper, H.H. Identification of N-(2-propenal)serine as a urinary metabolite of malondialdehyde. FASEB J. 1988, 2, 138-140.
51. Hadley, M.; Draper, H.H. Identification of N-(2-propenal)ethanolamine as a urinary metabolite of malondialdehyde. Free Radical Biol. Med. 1989, 6, 49-52.
52. Wang, J.-Y.; Wang, Z.-Y.; Kouyama, T.; Shibata, T.; Ueki, T. Significance of amino groups of phosphatidylethanolamine in phospholipid peroxidation of mixed liposomes. Chem. Phys. Lipids 1994, 71, 197-203.
53. Ravandi, A.; Kuksis, A.; Marai, L.; Myher, J.J. Preparation and characterization of glucosylated aminoglycerophospholipids. Lipids 1995, 30, 885-891.
54. Requena, J.R.; Ahmed, M.U.; Fountain, C.W.; Degenhardt, T.P.; Reddy, S.; Perez, C.; Lyons, T.J.; Jenkins, A.J.; Baynes, J.W.; Thorpe, S.R. Carboxymethylethanolamine, a biomarker of phospholipid modification during the Maillard reaction in vivo. J. Biol. Chem. 1997, 272, 17473-17479.
55. Lederer, M.O.; Dreisbusch, C.M.; Bundschuh, R.M. Amadori products from model reactions of D-glucose with phosphatidyl ethanolamine. Independent synthesis and identification of 1-deoxy-1-(2-hydroxyethylamino)-D-fructose derivatives. Carbohyd. Res. 1997, 301, 111-121.
56. Lertsiri, S.; Shiraishi, M.; Miyazawa, T. Identification of deoxy-D-fructosyl phosphatidyl ethanolamine as a non-enzymic glycation product of phosphatidyl ethanolamine and its occurrence in human blood plasma and red blood cells. Biosci. Biotechnol. Biochem. 1998, 62, 893-901.
57. Argirov, O.K.; Kerina, I.I.; Uzunova, J.I.; Argirova, M.D. Modeling of Protein and Aminophospholipid Glycation Using Low Molecular Weight Analogs. A Comparative Study. In The Maillard Reaction in Foods and Medicine; O'brien, J., Nursten, H.E., Crabbe, M.J.C., Ames, J.M., Eds.; The Royal Society of Chemistry: Cambridge, UK, 1998; pp. 245-249.
58. Fountain, W.C.; Requena, J.R.; Jenkins, A.J.; Lyons, T.J.; Smyth, B.; Baynes, J.W.; Thorpe, S.R. Quantification of N-(Glucitol)ethanolamine and N-(Carboxymethyl)serine: Two products of nonenzymatic modification of aminophospholipids formed in vivo. Anal. Biochem. 1999, 272, 48-55.
59. Heller, J.I.; Crowley, J.R.; Hazen, S.L.; Salvay, D.M.; Wagner, P.; Pennathur, S.; Heinecke, J.W. p-Hydroxyphenylacetaldehyde, an aldehyde generated by myeloperoxidase, modififes phospholipid amino groups of low density lipoprotein in human atherosclerotic intima. J. Biol. Chem. 2000, 275, 9957-9962.
60. Lederer, M.O.; Baumann, M. Formation of a phospholipid-linked pyrrolecarbaldehyde from model reactions of D-glucose and 3-deoxyglucosone with phosphatidyl ethanolamine. Bioorgan. Med. Chem. 2000, 8, 115-121.
61. Utzmann, C.M.; Lederer, M.O. Independent synthesis of aminophospholipid-linked Maillard products. Carbohyd. Res. 2000, 325, 157-168.
62. Zamora, R.; Hidalgo, F.J. Phosphatidylethanolamine modification by oxidative stress product 4,5(E)-epoxy-2(E)-heptenal. Chem. Res. Toxicol. 2003, 16, 1632-1641.
63. Tsuji, K.; Kawai, Y.; Kato, Y.; Osawa, T. Formation of N-(hexanoyl)ethanolamine, a novel phosphatidylethanolamine adduct, during the oxidation of erythrocyte membrane and low-density lipoprotein. Biochem. Biophys. Res. Commun. 2003, 306, 706-711.
64. Bacot, S.; Bernoud-Hubac, N.; Baddas, N.; Chantegrel, B.; Deshayes, C.; Doutheau, A.; Lagarde, M.; Guichardant, M. Covalent binding of hydroxyl-alkenals 4-HDDE, 4-HHE, and 4-HNE to ethanolamine phospholipid subclasses. J. Lipid Res. 2003, 44, 917-926.
65. Bernoud-Hubac, N.; Fay, L.B.; Armarnath, V.; Guichardant, M.; Bacot, S.; Davies, S.S.; Jackson Roberts, L., II; Lagarde, M. Covalent binding of isoketals to ethanolamine phospholipids. Free Radical Biol. Med. 2004, 37, 1604-1611.
66. Stadelmann-Ingrand, S.; Pontcharraud, R.; Fauconneau, B. Evidence for the reactivity of fatty aldehydes released from oxidized plasmalogens with phosphatidylethanolamine to form Schiff base adducts in rat brain homogenates. Chem. Phys. Lipids 2004, 131, 93-105.
67. Higuchi, O.; Nakagawa, K.; Tsuzuki, T.; Suzuki, T.; Oikawa, S.; Miyazawa, T. Aminophospholipid glycation and its inhibitor screening system: A new role of pyridoxal 5'-phosphate as the inhibitor. J. Lipid Res. 2006, 47, 964-974.
68. Miyazawa, T.; Ibusuki, D.; Yamashita, S.; Nakagawa, K. Analysis of amadori-glycated phosphatidylethanolamine in the plasma of healthy subjects and diabetic patients by liquid chromatography-tandem mass spectrometry. Ann. N. Y. Acad. Sci. 2008, 1126, 291-294.
69. Aguilar-Hernandez, M.; Mendez, J.D. In vitro glycation of brain aminophospholipids by acetoacetate and its inhibition by urea. Biomed. Pharmacother. 2007, 61, 693-697.
70. Solis-Calero, C.; Ortega-Castro, J.; Muñoz, F. Reactivity of a phospholipid monolayer model under periodic boundary conditions: A density functional theory study of the Schiff base formation between phosphatidylethanolamine and acetaldehyde. J. Phys. Chem. 2010, 114, 15879-15885.
71. Guo, L.; Chen, Z.; Amarnath, V.; Davies, S.S. identification of novel bioactive aldehyde-modified phosphatidylethanolamines formed by lipid peroxidation. Free Radic. Biol. Med. 2012, 53, 1226-1238.
72. Bucala, R.; Makita, Z.; Koschinsky, T.; Cerami, A.; Vlassara, H. Lipid advanced glycosylation: Pathway for lipid oxidation in vivo. Proc. Natl. Acad. Sci. USA 1993, 90, 6434-6438.
73. Pamplona, R.; Bellmunt, M. J.; Portero-Otin, M.; Riba, D.; Prat, J. Chromatographic evidence for Amadori product formation in rat liver aminophospholipids. Life Sci. 1995, 57, 873-879.
74. Pamplona, R.; Requena, J.R.; Portero-Otin, M.; Prat, J.; Thorpe, S.R.; Bellmunt, M.J. Carboxymethylated phosphatidylethanolamine in mitochondrial membranes of mammals. Evidence for intracellular lipid glycoxidation. Eur. J. Biochem. 1998, 225, 685-689.
75. Requena, J.R.; Ahmed, M.U.; Reddy, S.; Fountain, C.W.; Degenhardt, T.P.; Jenkins, A.J.; Smyth, B.; Lyons, T.J.; Thorpe, S.R. Detection of AGE-Lipids in vivo: Glycation and Carboxymethylation of Aminophospholipids in Red Cell Membranes. In The Maillard Reaction in Foods and Medicine; O'brien, J., Nursten, H.E., Crabbe, M.J.C., Ames, J.M., Eds.; The Royal Society of Chemistry: Cambridge, UK, 1998; pp. 363-368.
76. Oak, J.-H.; Nakagawa, K.; Miyazawa, T. UV analysis of Amadori-glycated phosphatidylethanolamine in foods and biological samples. J. Lipid Res. 2002, 43, 523-529.
77. Ravandi, A.; Kuksis, A.; Marai, L.; Myher, J.J.; Steiner, G.; Lewisa, G.; Kamido, H. Isolation and identification of glycated aminophospholipids from red cells and plasma of diabetic blood. FEBS Lett. 1996, 381, 77-81.
78. Ravandi, A.; Kuksis, A.; Shaikh, N.; Jackowski, G. Preparation of Schiff base adducts of phosphatidylcholine core aldehydes and aminophospholipids, amino acids, and myoglobin. Lipids 1997, 32, 989-1001.
79. Ravandi, A.; Kuksis, A.; Shaikh, N.A. Glycated phosphatidylethanolamine promotes macrophage uptake of low density lipoprotein and accumulation of cholesteryl esters and triacylglycerols. J. Biol. Chem. 1999, 274, 16494-16500.
80. Reddy, S.; Bichler, J.; Wells-Knecht, K.J.; Thorpe, S.R.; Baynes, J.W. Ne-(Carboxymethyl)lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochemistry 1995, 34, 10872-10878.
81. Jenkins, A.; Lyons, T.J.; Smyth, B.; Requena, J.R.; Fountain, C.W.; Hermayer, K.L.; Phillips, K.D.; King, L.P.; Baynes, J.W.; Thorpe, S.R. Glycoxidation and lipoxidation products in red blood cell membranes in IDDM. Relationship to glycemic control and microvascular complications. Diabetes 1998, 47, A127.
82. Fu, M.X.; Requena, J.R.; Jenkins, A.J.; Lyons, T.J.; Baynes, J.W.; Thorpe, S.R. The advanced glycation end product Ne-(Carboxymethyl)lysine is a product of both lipid peroxidation and glycoxidation reactions. J. Biol. Chem. 1996, 271, 9982-9986.
83. Anderson, M.M.; Requena, J.R.; Crowley, J.R.; Thorpe, S.R.; Heinecke, J.W. The myeloperoxidase system of human phagocytes generates Ne-(carboxymethyl)lysine on proteins: A mechanism for producing advanced glycation end products at sites of inflammation. J. Clin. Invest. 1999, 104, 103-113.
84. Prat, J., Bellmunt, M.J., Portero-Otín, M., Pamplona, R. Fluorescent Products from Aminophospholipids and Glucose. In The Maillard Reaction in Foods and Medicine; O'brien, J., Nursten, H.E., Crabbe, M.J.C., Ames, J.M., Eds.; The Royal Society of Chemistry: Cambridge, UK, 1998; p. 438.
85. Al-Abed, Y.; Liebich, H.; Voelter, W.; Bucala, R. Hydroxyalkenal formation induced by advanced glycosylation of low density lipoprotein. J. Biol. Chem. 1996, 271, 2892-2896.
86. Obsil, T.; Amler, E.; Obsilova, V.; Pavlicek, Z. Effect of aminophospholipid glycation on order parameter and hydration of phospholipid bilayer. Biophys. Chem. 1999, 80, 165-177.
87. Ravandi, A.; Kuksis, A.; Shaikh, N.A. Glucosylated glycerophosphoethanolamines are the major LDL glycation products and increase LDL susceptibility to oxidation. Arterioscl. Throm. Vas. Biol. 2000, 20, 467-477.
88. Utzmann, C.M.; Lederer, M.O. Identification and quantification of aminophospholipid-linked Maillard compounds in model systems and egg yolk products. J. Agric. Food Chem. 2000, 48, 1000-1008.
89. Oak, J.-H.; Nakagawa, K.; Miyazawa, T. Synthetically prepared Amadori-glycated phosphatidylethanolamine can trigger lipid peroxidation via free radical reactions. FEBS Lett. 2000, 481, 26-30.
90. Breitling-Utzmann, C.M.; Unger, A.; Friedl, D.A.; Lederer, M.O. Identification and quantification of phosphatidylethanolamine-derived glucosylamines and aminoketoses from human erythrocytes-Influence of glycation products on lipid peroxidation. Archives Biochem. Biophys. 2001, 391, 245-254.
91. Lecompte, M-F.; Clavilier, J.; Rolland, C.; Collet, X.; Negre-Salvayre, A.; Salvayre, R. Effect of 4-hydroxynonenal on phosphatidylethanolamine containing condensed monolayer and on its interaction with apolipoprotein A-I. FEBS Lett. 2005, 579, 5074-5078.
92. Levi, V.; Villamil Giraldo, A.M.; Castello, P.R.; Rossi, J.P.F.C.; Gonzalez Flecha, F.L. Effects of phosphatidylethanolamine glycation on lipid-protein interactions and membrane protein thermal stability. Biochem. J. 2008, 416, 145-152.
93. Simoes, C.; Simoes, V.; Reis, A.; Domingues, P.; Domingues, M.R.M. Oxidation of glycated phosphatidylethanolamines: Evidence of oxidation in glycated polar head identified by LC-MS/MS. Anal. Bioanal. Chem. 2010, 397, 2417-2427.
94. Simoes, C.; Domingues, P.; Domingues, M.R.M. Identification of free radicals in oxidized and glycoxidized phosphatidylethanolamines by spin trapping combined with tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2012, 26, 931-939.
95. Herrmann, A.; Devaux, P.F. Alteration of the aminophospholipid translocase activity during in vivo and artificial aging of human erythrocytes. Biochim. Biophys. Acta1990, 1027, 41-46.
96. Zieseniss, S.; Zahler, S.; Müller, I.; Hermetter, A.; Engelmann, B. Modified phosphatidylethanolamine as the active component of oxidized low density lipoprotein promoting platelet prothrombinase activity. J. Biol. Chem. 2001, 276, 19828-19835.
97. Guichardant, M.; Bernoud-Hubac, N.; Chantegrel, B.; Deshayes, C.; Lagarde, M. Aldehydes from n-6 fatty acid peroxidation. Effects on aminophospholipids. Protag. Leukotr. Ess. Fatty Acids 2002, 67, 147-149.
98. Oak, J.-H.; Nakagawa, K.; Oikawa, S.; Miyazawa, T. Amadori-glycated phosphatidylethanolamine induces angiogenic differentiations in cultured human umbilical vein endothelial cells. FEBS Lett. 2003, 555, 419-423.
99. Nakagawa, K.; Oak, J.-H.; Miyazawa, T. Angiogenic potency of Amadori-glycated phosphatidylethanolamine. Ann. N. Y. Acad. Sci. 2005, 1043, 413-416.
100. Bacot, S.; Bernoud-Hubac, N.; Chantegrel, B.; Deshayes, C.; Doutheau, A.; Ponsin, G.; Lagarde, M.; Guichardant, M. Evidence for in situ ethanolamine phospholipid adducts with hydroxyl-alkenals. J. Lipid Res. 2007, 48, 816-825.
101. Fadok, V.A.; Bratton, D.L.; Frasch, S.C.; Warner, M.L.; Henson, P.M. The role of phosphatidylserine in recognition of apoptotic cells by phagocytes. Cell Death Differ. 1998, 5, 551-562.
102. Brenner, R.R. Effect of unsaturated acids on membrane structure and enzyme kinetics. Prog. Lipid Res. 1984, 23, 69-96.
103. Daum, G. Lipids of mitochondria. Biochim. Biophys. Acta 1985, 822, 1-42.
104. Tyler, D. The Mitochondrion in Health and Disease; VCH Publishers: New York, NY, USA, 1992; pp. 78-80.
105. Nakagawa, K.; Oak, J-H.; Higuchi, O.; Tsuzuki, T.; Oikawa, S.; Otani, H.; Mune, M.; Cai, H.; Miyazawa, T. Ion-trap tándem mass spectrometric analysis of Amadori-glycated phosphatidylethanolamine in human plasma with or without diabetes. J. Lipid Res. 2005, 46, 2514-2524.
106. Miyazawa, T.; Oak, J.-H.; Nakagawa, K. tándem mass spectrometry analysis of Amadori-glycated phosphatidylethanolamine in human plasma. Ann. N. Y. Acad. Sci. 2005, 1043, 280-283.
107. Shoji, N.; Nakagawa, K.; Asai, A.; Fujita, I.; Hashiura, A.; Nakajima, Y.; Oikawa, S.; Miyazawa, T. LC-MS/MS analysis of carboxymethylated and carboxyethylated phosphatidylethanolamines in human erythrocytes and blood plasma. J. Lipid Res. 2010, 51, 2445-2453.
108. Sookwong, P.; Nakagawa, K.; Fujita, I.; Shoji, N.; Miyazawa, T. Amadori-glycated phosphatidylethanolamine, a potential marker for hyperglycemia, in streptozotocin-induced diabetic rats. Lipids 2011, 46, 943-952.
109. Sell, D.R.; Lane, M.A.; Johnson, W.A.; Masoro, E.J.; Mock, O.B.; Reiser, K.M.; Fogarty, J.F.; Cutler, R.G.; Ingram, D.K.; Roth, G.S.; et al. Longevity and the genetic determination of collagen glycoxidation kinetics in mammalian senescence. Proc. Natl. Acad. Sci. USA 1996, 93, 485-490.
110. Baynes, J.W.; Thorpe, S.R. Role of oxidative stress in diabetic complications. A new perspective on an old paradigm. Diabetes 1999, 48, 1-9.
111. Prat, J.; Pamplona, R.; Sorribas, A.; Martín, S.; Viñallonga, M.; Segura, R. Correlation of plasma lipid fractions with colorimetrically determined glycated hemoglobin in a nondiabetic population. Metabolism 1989, 38, 1147-1153.
112. Pamplona, R.; Belmunt, M.J.; Portero-Otín, M.; Prat, J. Mechanisms of glycation in atherogenesis. Med. Hypotheses 1993, 40, 174-181.
113. Wautier, J.L.; Wautier, M.P.; Schmidt, A.M.; Anderson, G.M.; Hori, O.; Zoukourian, C.; Capron, L.; Chappey, O.; Yan, S.D.; Brett, J.; et al. Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: A link between surface-associated AGEs and diabetic complications. Proc. Natl. Acad. Sci. USA 1994, 91, 7742-7746.
114. Kislinger, T.; Fu, C.; Huber, B.; Qu, W.; Taguchi, A.; Du Yan, S.; Hofmann, M.; Yan, S.F.; Pischetsrieder, M.; Stern, D.; et al. N(epsilon)-(carboxymethyl)lysine adducts of proeins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J. Biol. Chem. 1999, 274, 31740-31749.